These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30145112)

  • 1. Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations.
    Railkar R; Agarwal PK
    Eur Urol Focus; 2018 Jul; 4(4):509-511. PubMed ID: 30145112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.
    Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD
    J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial).
    Filonenko EV; Kaprin AD; Alekseev BY; Apolikhin OI; Slovokhodov EK; Ivanova-Radkevich VI; Urlova AN
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():106-109. PubMed ID: 27671517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle invasive bladder cancer.
    Lee LS; Thong PS; Olivo M; Chin WW; Ramaswamy B; Kho KW; Lim PL; Lau WK
    Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):213-20. PubMed ID: 21112542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.
    Yavari N; Andersson-Engels S; Segersten U; Malmstrom PU
    Can J Urol; 2011 Aug; 18(4):5778-86. PubMed ID: 21854709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
    Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
    Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
    Inoue K
    Int J Urol; 2017 Feb; 24(2):97-101. PubMed ID: 28191719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
    Kiss B; van den Berg NS; Ertsey R; McKenna K; Mach KE; Zhang CA; Volkmer JP; Weissman IL; Rosenthal EL; Liao JC
    Clin Cancer Res; 2019 Jun; 25(12):3561-3571. PubMed ID: 30890547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
    van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
    Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-based nanotechnology: antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy.
    Jankun J
    Int J Oncol; 2011 Oct; 39(4):949-53. PubMed ID: 21725592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
    Bader MJ; Stepp H; Beyer W; Pongratz T; Sroka R; Kriegmair M; Zaak D; Welschof M; Tilki D; Stief CG; Waidelich R
    Urol Oncol; 2013 Oct; 31(7):1178-83. PubMed ID: 22440147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy.
    St Denis TG; Hamblin MR
    Bioanalysis; 2013 May; 5(9):1099-114. PubMed ID: 23641699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
    Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
    Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoimmunotherapy Using Cationic and Anionic Photosensitizer-Antibody Conjugates against HIV Env-Expressing Cells.
    Sadraeian M; Bahou C; da Cruz EF; Janini LMR; Sobhie Diaz R; Boyle RW; Chudasama V; Eduardo Gontijo Guimarães F
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Photodynamic therapy and urothelial carcinoma].
    Colin P; Estevez JP; Betrouni N; Nevoux P; Puech P; Leroy X; Biserte J; Villers A; Mordon S
    Bull Cancer; 2011 Jul; 98(7):769-78. PubMed ID: 21708516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
    Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
    Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
    Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
    Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapy.
    Sanchez-Barcelo EJ; Mediavilla MD
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):1-8. PubMed ID: 24372346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer.
    Staneloudi C; Smith KA; Hudson R; Malatesti N; Savoie H; Boyle RW; Greenman J
    Immunology; 2007 Apr; 120(4):512-7. PubMed ID: 17343613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.